¿La diana de Hb de 13,5 g/dl frente a 11,3 g/dl, en el tratamiento con EPO en la enfermedad renal crónica estadios 3 y 4, disminuye los sucesos cardiovasculares y la mortalidad?
Does the target of an Hb value of 13.5 g/dL versus 11.3 g/dL in EPO-managed stages 3 and 4 chronic renal disease decrease cardiovascular events and mortality?
R. Saracho
Leído
5997
Vecesse ha leído el artículo
2316
Total PDF
3681
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 59 | 84 | 143 |
| 2025 5 | 87 | 32 | 119 |
| 2025 4 | 51 | 23 | 74 |
| 2025 3 | 70 | 49 | 119 |
| 2025 2 | 54 | 25 | 79 |
| 2025 1 | 47 | 40 | 87 |
| 2024 12 | 37 | 20 | 57 |
| 2024 11 | 33 | 35 | 68 |
| 2024 10 | 34 | 29 | 63 |
| 2024 9 | 26 | 24 | 50 |
| 2024 8 | 39 | 49 | 88 |
| 2024 7 | 28 | 29 | 57 |
| 2024 6 | 39 | 27 | 66 |
| 2024 5 | 41 | 35 | 76 |
| 2024 4 | 39 | 25 | 64 |
| 2024 3 | 27 | 21 | 48 |
| 2024 2 | 30 | 34 | 64 |
| 2024 1 | 23 | 25 | 48 |
| 2023 12 | 32 | 18 | 50 |
| 2023 11 | 23 | 29 | 52 |
| 2023 10 | 22 | 40 | 62 |
| 2023 9 | 25 | 25 | 50 |
| 2023 8 | 25 | 18 | 43 |
| 2023 7 | 29 | 32 | 61 |
| 2023 6 | 37 | 17 | 54 |
| 2023 5 | 36 | 24 | 60 |
| 2023 4 | 12 | 11 | 23 |
| 2023 3 | 20 | 23 | 43 |
| 2023 2 | 24 | 23 | 47 |
| 2022 1 | 31 | 30 | 61 |
| 2022 12 | 21 | 33 | 54 |
| 2022 11 | 29 | 29 | 58 |
| 2022 10 | 25 | 40 | 65 |
| 2022 9 | 25 | 26 | 51 |
| 2022 8 | 25 | 38 | 63 |
| 2022 7 | 29 | 52 | 81 |
| 2022 6 | 14 | 25 | 39 |
| 2022 5 | 15 | 37 | 52 |
| 2022 4 | 33 | 49 | 82 |
| 2022 3 | 14 | 41 | 55 |
| 2022 2 | 38 | 34 | 72 |
| 2021 1 | 24 | 32 | 56 |
| 2021 12 | 16 | 29 | 45 |
| 2021 11 | 29 | 34 | 63 |
| 2021 10 | 23 | 35 | 58 |
| 2021 9 | 19 | 29 | 48 |
| 2021 8 | 24 | 29 | 53 |
| 2021 7 | 15 | 19 | 34 |
| 2021 6 | 23 | 23 | 46 |
| 2021 5 | 24 | 29 | 53 |
| 2021 4 | 49 | 44 | 93 |
| 2021 3 | 31 | 16 | 47 |
| 2021 2 | 27 | 8 | 35 |
| 2020 1 | 16 | 10 | 26 |
| 2020 12 | 20 | 9 | 29 |
| 2020 11 | 8 | 6 | 14 |
| 2020 10 | 19 | 7 | 26 |
| 2020 9 | 11 | 4 | 15 |
| 2020 8 | 18 | 2 | 20 |
| 2020 7 | 26 | 11 | 37 |
| 2020 6 | 27 | 5 | 32 |
| 2020 5 | 18 | 9 | 27 |
| 2020 4 | 28 | 15 | 43 |
| 2020 3 | 23 | 12 | 35 |
| 2020 2 | 31 | 22 | 53 |
| 2020 1 | 51 | 15 | 66 |
| 2019 12 | 23 | 15 | 38 |
| 2019 11 | 26 | 6 | 32 |
| 2019 10 | 36 | 20 | 56 |
| 2019 9 | 45 | 15 | 60 |
| 2019 8 | 38 | 22 | 60 |
| 2019 7 | 38 | 15 | 53 |
| 2019 6 | 26 | 13 | 39 |
| 2019 5 | 21 | 12 | 33 |
| 2019 4 | 78 | 39 | 117 |
| 2019 3 | 10 | 17 | 27 |
| 2019 2 | 13 | 10 | 23 |
| 2019 1 | 12 | 6 | 18 |
| 2018 12 | 29 | 22 | 51 |
| 2018 11 | 21 | 23 | 44 |
| 2018 10 | 15 | 23 | 38 |
| 2018 9 | 21 | 24 | 45 |
| 2018 8 | 16 | 12 | 28 |
| 2018 7 | 12 | 17 | 29 |
| 2018 6 | 11 | 10 | 21 |
| 2018 5 | 13 | 11 | 24 |
| 2018 4 | 21 | 11 | 32 |
| 2018 3 | 14 | 9 | 23 |
| 2018 2 | 14 | 7 | 21 |
| 2018 1 | 20 | 11 | 31 |
| 2017 12 | 13 | 9 | 22 |
| 2017 11 | 12 | 9 | 21 |
| 2017 10 | 8 | 11 | 19 |
| 2017 9 | 12 | 17 | 29 |
| 2017 8 | 11 | 14 | 25 |
| 2017 7 | 8 | 7 | 15 |
| 2017 6 | 17 | 17 | 34 |
| 2017 5 | 9 | 19 | 28 |
| 2017 4 | 10 | 5 | 15 |
| 2017 3 | 13 | 16 | 29 |
| 2017 2 | 8 | 10 | 18 |
| 2016 1 | 7 | 7 | 14 |
| 2016 12 | 20 | 9 | 29 |
| 2016 11 | 16 | 8 | 24 |
| 2016 10 | 23 | 19 | 42 |
| 2016 9 | 47 | 8 | 55 |
| 2016 8 | 70 | 2 | 72 |
| 2016 7 | 75 | 5 | 80 |
| 2016 6 | 62 | 0 | 62 |
| 2016 5 | 76 | 0 | 76 |
| 2016 4 | 48 | 0 | 48 |
| 2016 3 | 32 | 0 | 32 |
| 2016 2 | 51 | 0 | 51 |
| 2015 1 | 44 | 0 | 44 |
| 2015 12 | 55 | 0 | 55 |
| 2015 11 | 32 | 0 | 32 |
| 2015 10 | 34 | 0 | 34 |
| 2015 9 | 30 | 0 | 30 |
| 2015 8 | 18 | 0 | 18 |
| 2015 7 | 34 | 0 | 34 |
| 2015 6 | 13 | 0 | 13 |
| 2015 5 | 46 | 0 | 46 |
| 2015 4 | 1 | 0 | 1 |
| 2015 2 | 205 | 0 | 205 |
Mostrar todo
